Jeremy N Rich Selected Research

ibrutinib

1/2018	Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
11/2017	Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeremy N Rich Research Topics

Disease

152	Neoplasms (Cancer) 05/2024 - 05/2002
104	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 01/2004
77	Glioma (Gliomas) 03/2024 - 03/2002
36	Brain Neoplasms (Brain Tumor) 03/2024 - 01/2003
13	Hypoxia (Hypoxemia) 12/2023 - 08/2006
10	Carcinogenesis 05/2024 - 01/2011
4	Ependymoma 11/2020 - 11/2005
3	Medulloblastoma 12/2023 - 10/2008
3	Zika Virus Infection 12/2022 - 01/2020
3	Infections 12/2022 - 02/2009
3	Leukemia 01/2022 - 07/2018
3	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2004
3	Triple Negative Breast Neoplasms 12/2020 - 12/2013
3	Tics (Tic) 01/2016 - 08/2013
3	Colonic Neoplasms (Colon Cancer) 01/2013 - 04/2004
3	Diarrhea 07/2012 - 01/2004
3	Astrocytoma (Pilocytic Astrocytoma) 01/2008 - 01/2006
2	Starvation 01/2023 - 01/2017
2	Meningioma (Meningiomas) 01/2022 - 11/2020
2	Breast Neoplasms (Breast Cancer) 12/2020 - 12/2013
2	Obesity 12/2020 - 12/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 12/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2012 - 05/2008

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2003
13	Phosphotransferases (Kinase)IBA 03/2015 - 12/2004
12	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 02/2003
12	Bevacizumab (Avastin)FDA Link 01/2023 - 08/2006
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 08/2006
10	Irinotecan (Camptosar)FDA LinkGeneric 12/2011 - 04/2004
9	ErbB Receptors (EGF Receptor)IBA 12/2023 - 01/2004
9	Transcription Factors (Transcription Factor)IBA 12/2022 - 04/2011
8	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 05/2005
8	EnzymesIBA 01/2023 - 02/2006
8	ChromatinIBA 01/2022 - 05/2015
8	Tyrosine Kinase InhibitorsIBA 07/2012 - 01/2004
7	CytokinesIBA 01/2024 - 01/2003
7	Growth Factor ReceptorsIBA 01/2023 - 01/2005
7	Monoclonal AntibodiesIBA 11/2008 - 03/2002
6	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2013
5	UbiquitinIBA 03/2024 - 01/2017
5	Histones (Histone)IBA 01/2023 - 12/2015
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2023 - 06/2008
5	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2008
5	Oxygen (Dioxygen)IBA 11/2020 - 10/2009
5	IntegrinsIBA 01/2020 - 05/2010
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 10/2006
4	Ligases (Synthetase)IBA 03/2024 - 05/2015
4	CholesterolIBA 01/2024 - 11/2020
4	6-methyladenineIBA 12/2023 - 01/2021
4	Lysine (L-Lysine)FDA Link 01/2023 - 11/2020
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023 - 02/2006
4	Antiviral Agents (Antivirals)IBA 12/2022 - 01/2020
4	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2014
4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 05/2004
4	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 12/2005
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2012 - 11/2005
4	O(6)-benzylguanineIBA 10/2009 - 05/2002
4	Carmustine (FIVB)FDA Link 08/2009 - 05/2002
3	IronIBA 03/2024 - 10/2015
3	Deubiquitinating EnzymesIBA 03/2024 - 01/2017
3	N-methyladenosineIBA 12/2023 - 10/2017
3	Messenger RNA (mRNA)IBA 01/2023 - 02/2010
3	LipidsIBA 12/2022 - 01/2019
3	Methionine (L-Methionine)FDA Link 07/2022 - 05/2017
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 12/2005
3	Tyrosine (L-Tyrosine)FDA Link 11/2021 - 06/2007
3	Neutralizing AntibodiesIBA 01/2021 - 08/2006
3	InterferonsIBA 01/2021 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 10/2013
3	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2012 - 12/2005
3	LigandsIBA 06/2012 - 06/2004
3	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 03/2011 - 08/2008
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 10/2006 - 01/2005
3	Gefitinib (Iressa)FDA Link 02/2006 - 01/2004
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2005 - 01/2003
3	Topoisomerase I InhibitorsIBA 10/2005 - 04/2004
2	Cysteine (L-Cysteine)FDA Link 03/2024 - 12/2004
2	ChemokinesIBA 01/2022 - 12/2013
2	Platelet-Derived Growth FactorIBA 01/2022 - 06/2012
2	Oncogene Proteins (Oncogene Protein)IBA 11/2021 - 07/2014
2	VaccinesIBA 01/2021 - 01/2021
2	Interferon Type IIBA 01/2020 - 01/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 10/2006
2	CateninsIBA 01/2020 - 05/2013
2	NexusIBA 01/2019 - 01/2017
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2018 - 05/2014
2	ibrutinibIBA 01/2018 - 11/2017
2	AntibodiesIBA 01/2017 - 01/2013
2	Ferritins (Ferritin)IBA 01/2017 - 10/2015
2	Green Fluorescent ProteinsIBA 07/2015 - 03/2015
2	PeriostinIBA 02/2015 - 04/2004
2	Biomarkers (Surrogate Marker)IBA 07/2014 - 09/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2013 - 07/2011
2	Laminin (Merosin)IBA 11/2012 - 03/2012

Therapy/Procedure

83	Therapeutics 05/2024 - 08/2002
25	Drug Therapy (Chemotherapy) 03/2024 - 01/2004
12	Radiotherapy 01/2023 - 02/2006
5	Immunotherapy 01/2023 - 01/2016
4	Salvage Therapy 03/2012 - 02/2007
2	Transplantation 01/2016 - 06/2011